vs

Side-by-side financial comparison of Canopy Growth Corp (CGC) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.

Canopy Growth Corp is the larger business by last-quarter revenue ($54.4M vs $30.9M, roughly 1.8× Community Healthcare Trust Inc). Community Healthcare Trust Inc runs the higher net margin — 46.6% vs -84.0%, a 130.6% gap on every dollar of revenue. On growth, Community Healthcare Trust Inc posted the faster year-over-year revenue change (5.6% vs -0.3%). Over the past eight quarters, Community Healthcare Trust Inc's revenue compounded faster (2.7% CAGR vs 1.2%).

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

CGC vs CHCT — Head-to-Head

Bigger by revenue
CGC
CGC
1.8× larger
CGC
$54.4M
$30.9M
CHCT
Growing faster (revenue YoY)
CHCT
CHCT
+5.9% gap
CHCT
5.6%
-0.3%
CGC
Higher net margin
CHCT
CHCT
130.6% more per $
CHCT
46.6%
-84.0%
CGC
Faster 2-yr revenue CAGR
CHCT
CHCT
Annualised
CHCT
2.7%
1.2%
CGC

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CGC
CGC
CHCT
CHCT
Revenue
$54.4M
$30.9M
Net Profit
$-45.7M
$14.4M
Gross Margin
28.8%
Operating Margin
-35.3%
Net Margin
-84.0%
46.6%
Revenue YoY
-0.3%
5.6%
Net Profit YoY
48.6%
687.6%
EPS (diluted)
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGC
CGC
CHCT
CHCT
Q4 25
$54.4M
$30.9M
Q3 25
$48.7M
$31.1M
Q2 25
$52.7M
$29.1M
Q1 25
$47.5M
$30.1M
Q4 24
$54.6M
$29.3M
Q3 24
$46.0M
$29.6M
Q2 24
$48.3M
$27.5M
Q1 24
$53.1M
$29.3M
Net Profit
CGC
CGC
CHCT
CHCT
Q4 25
$-45.7M
$14.4M
Q3 25
$-1.2M
$1.6M
Q2 25
$-30.3M
$-12.6M
Q1 25
$1.6M
Q4 24
$-89.0M
$1.8M
Q3 24
$-93.7M
$1.7M
Q2 24
$-92.8M
$-10.4M
Q1 24
$3.7M
Gross Margin
CGC
CGC
CHCT
CHCT
Q4 25
28.8%
Q3 25
32.8%
Q2 25
25.0%
Q1 25
16.2%
Q4 24
32.2%
Q3 24
34.7%
Q2 24
34.8%
Q1 24
21.3%
Operating Margin
CGC
CGC
CHCT
CHCT
Q4 25
-35.3%
Q3 25
-25.3%
Q2 25
-31.4%
Q1 25
Q4 24
-31.9%
Q3 24
-72.9%
Q2 24
-44.0%
Q1 24
Net Margin
CGC
CGC
CHCT
CHCT
Q4 25
-84.0%
46.6%
Q3 25
-2.5%
5.3%
Q2 25
-57.6%
-43.2%
Q1 25
5.3%
Q4 24
-163.0%
6.3%
Q3 24
-203.7%
5.9%
Q2 24
-192.0%
-37.9%
Q1 24
12.5%
EPS (diluted)
CGC
CGC
CHCT
CHCT
Q4 25
$0.52
Q3 25
$0.03
Q2 25
$-0.50
Q1 25
$0.03
Q4 24
$0.04
Q3 24
$0.04
Q2 24
$-0.42
Q1 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGC
CGC
CHCT
CHCT
Cash + ST InvestmentsLiquidity on hand
$271.1M
$3.3M
Total DebtLower is stronger
$532.2M
Stockholders' EquityBook value
$553.5M
$429.4M
Total Assets
$807.5M
$990.8M
Debt / EquityLower = less leverage
1.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGC
CGC
CHCT
CHCT
Q4 25
$271.1M
$3.3M
Q3 25
$217.6M
$3.4M
Q2 25
$104.8M
$4.9M
Q1 25
$96.0M
$2.3M
Q4 24
$130.2M
$4.4M
Q3 24
$168.8M
$2.8M
Q2 24
$142.3M
$734.0K
Q1 24
$148.5M
$3.8M
Total Debt
CGC
CGC
CHCT
CHCT
Q4 25
$532.2M
Q3 25
$530.1M
Q2 25
$500.1M
Q1 25
$496.0M
Q4 24
$486.0M
Q3 24
$473.7M
Q2 24
$457.6M
Q1 24
$442.3M
Stockholders' Equity
CGC
CGC
CHCT
CHCT
Q4 25
$553.5M
$429.4M
Q3 25
$537.3M
$426.8M
Q2 25
$357.0M
$437.8M
Q1 25
$355.7M
$461.3M
Q4 24
$431.8M
$476.0M
Q3 24
$372.1M
$477.2M
Q2 24
$389.0M
$497.8M
Q1 24
$365.3M
$511.6M
Total Assets
CGC
CGC
CHCT
CHCT
Q4 25
$807.5M
$990.8M
Q3 25
$781.0M
$987.3M
Q2 25
$660.4M
$966.3M
Q1 25
$669.9M
$985.1M
Q4 24
$849.9M
$992.6M
Q3 24
$899.6M
$981.8M
Q2 24
$938.9M
$983.2M
Q1 24
$949.2M
$982.7M
Debt / Equity
CGC
CGC
CHCT
CHCT
Q4 25
1.24×
Q3 25
1.24×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.02×
Q3 24
0.99×
Q2 24
0.92×
Q1 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGC
CGC
CHCT
CHCT
Operating Cash FlowLast quarter
$56.4M
Free Cash FlowOCF − Capex
$35.9M
FCF MarginFCF / Revenue
116.0%
Capex IntensityCapex / Revenue
66.3%
Cash ConversionOCF / Net Profit
3.91×
TTM Free Cash FlowTrailing 4 quarters
$62.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGC
CGC
CHCT
CHCT
Q4 25
$56.4M
Q3 25
$12.7M
Q2 25
$-7.5M
$13.8M
Q1 25
$-121.0M
$14.4M
Q4 24
$58.9M
Q3 24
$13.8M
Q2 24
$-37.8M
$16.7M
Q1 24
$-205.8M
$12.6M
Free Cash Flow
CGC
CGC
CHCT
CHCT
Q4 25
$35.9M
Q3 25
$7.6M
Q2 25
$-8.5M
$9.6M
Q1 25
$-128.9M
$9.7M
Q4 24
$34.2M
Q3 24
$6.7M
Q2 24
$-40.7M
$9.5M
Q1 24
$-208.3M
$7.5M
FCF Margin
CGC
CGC
CHCT
CHCT
Q4 25
116.0%
Q3 25
24.6%
Q2 25
-16.1%
32.9%
Q1 25
-271.5%
32.3%
Q4 24
116.9%
Q3 24
22.5%
Q2 24
-84.1%
34.7%
Q1 24
-392.1%
25.7%
Capex Intensity
CGC
CGC
CHCT
CHCT
Q4 25
66.3%
Q3 25
16.3%
Q2 25
1.8%
14.5%
Q1 25
16.6%
15.6%
Q4 24
84.1%
Q3 24
24.2%
Q2 24
5.9%
26.1%
Q1 24
4.7%
17.4%
Cash Conversion
CGC
CGC
CHCT
CHCT
Q4 25
3.91×
Q3 25
7.76×
Q2 25
Q1 25
9.06×
Q4 24
32.14×
Q3 24
7.92×
Q2 24
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGC
CGC

Other$24.0M44%
Canadian Adult Use Cannabis$22.9M42%
International Markets Cannabis$6.2M11%
Other Geographical Area$1.2M2%

CHCT
CHCT

Segment breakdown not available.

Related Comparisons